Angiex Inc: Valuation, Funding & Investors
Angiex Inc. is a privately held biotech company focused on exploiting newly discovered biological transport mechanisms to develop drugs with revolutionary power over cancer. Based in Cambridge, Mass., the company is developing a portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus of cells in the tumor environment, enhancing the efficacy and therapeutic margin of conventional ADCs.
Leadership & Board
- Current Number of Employees
- 10
- Current LinkedIn Followers
- 1,716
Latest Estimated Valuation
- Total Amount Raised
- $31M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $31M
- Latest Funding Round
- Investment
Employee Trend
Angiex Inc had 10 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Angiex Inc had 1,716 followers as of November 9, 2026. The number of followers increased by 9 (0.53%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 17, 2025 | Investment | $31.00M | ― |
Similar Companies
A snapshot of private companies similar to Angiex Inc, helping you discover and navigate related company profiles.
